Considerations for Selecting Samsung Mobile Devices for Global Clinical Trials

Samsung chats with mProve’s New Product Development Lead, Mindy Gruba, about considerations for selecting the right mobile device for each clinical trial. Check out the article here. covers mProve’s partnership with Greenphire

Adding patient payment information to mPal via the integration with Greenphire’s ClinCard brings us one step closer to offering patients all the services they could need for any trial.

Read more here.

Pharma Roundtable: Breaking Barriers to Using Mobile Technology on Clinical Trials

As a moderator at the Mobile in Clinical Trials event at DPharm in Boston in early September, CEO Jeff Lee had the opportunity to sit down with some of the pharmaceutical industry’s top mobile expert. He got their perspectives on quantifying and deriving value from mobile technologies, as well as how they get buy-in from study teams and executives to scale the use of these tools. Read the article published by Applied Clinical Trials here.

CenterWatch Weekly, September 18, 2017, Covers mProve and Greenphire’s Partnership

Jeff Lee, CEO, mProve Health, and Jim Murphy, CEO, Greenphire, comment on how their companies are joining forces to allow clinical trial patients real-time mobile access to a range of support functions through mProve’s app. Read more here.

mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution

mProve Health integrates ClinCard with its patient engagement app to boost retention, compliance and improve patients’ clinical trial experience.

DPharm: Disruptive Innovations to Advance Clinical Trials — BOSTON — September 6, 2017, mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), and Greenphire, the global leader in clinical payment automation, today announced a partnership to provide patients with real-time access to ClinCard payment details via mProve’s engagement app, mPal.


Page 1 of 512345